Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever…

Trump White House policy to ignore reporters using pronouns in emails brings praise and harsh criticism
Email signatures are the latest front in the culture wars, as the Trump White House derides reporters who list their “pronouns” as reality deniers.